Position in VRTX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$15,190,844
-$1,442,934 QoQ
Shares Held
34,019
-7.3% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Vestcor Inc holds $67,387,677 across 32 Biotechnology names. VRTX ranks #1 (22.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
34,019 | $15,190,844 | |
| 2 | INCY |
Incyte Corp
|
119,739 | $11,269,834 | |
| 3 | FOLD |
AMICUS THERAPEUTICS, INC.
|
447,412 | $6,469,577 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
63,077 | $6,134,238 | |
| 5 | EXEL |
Exelixis, Inc.
|
138,065 | $5,921,607 | |
| 6 | TERN |
Terns Pharmaceuticals, Inc.
|
100,000 | $5,272,000 | |
| 7 | ACLX |
Arcellx, Inc.
|
19,578 | $2,247,945 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,319 | $1,759,897 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $15,190,844 | 34,019 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $16,633,778 | 36,690 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $13,811,576 | 35,266 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $14,018,457 | 31,488 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $15,582,599 | 32,141 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $21,194,503 | 52,631 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $30,348,795 | 65,255 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $30,012,610 | 64,031 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $27,066,983 | 64,752 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $28,868,031 | 70,948 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $25,382,238 | 72,992 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $26,817,301 | 76,205 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $24,473,062 | 77,675 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $24,328,559 | 84,246 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $23,082,707 | 79,722 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $21,050,276 | 74,702 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $18,713,636 | 71,708 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,352,077 | 6,157 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $1,288,594 | 7,104 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $9,272,157 | 45,986 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $10,011,939 | 46,591 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $9,171,410 | 38,806 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $7,347,784 | 27,002 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $6,543,006 | 22,538 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,310,152 | 5,506 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||